Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A

BACKGROUND: Gene therapy provides a novel method for the prevention and treatment of cancer, but the clinical application of gene therapy is restricted, mainly because of the absence of an efficient and safe gene delivery system. Recently, we developed a novel nonviral gene carrier, ie, heparin-poly...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhang, Ling, Gao, Xiang, Men, Ke, Wang, BiLan, Zhang, Shuang, Qiu, Jinfeng, Huang, Meijuan, Gou, MaLing, Huang, Ning, Qian, ZhiYong, Zhao, Xia, Wei, YuQuan
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2011
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3205136/
https://ncbi.nlm.nih.gov/pubmed/22072877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S23582
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars